Healthcare group McKesson and private equity firm Clayton Dubilier & Rice are closing in on a deal to buy the largest independent provider of medical infusion services in the US, valuing the business at more than $5bn including debt.
October 6, 2026 - 15:31
By Pharos Investment Advisors Comments are Off
Healthcare group McKesson and private equity firm Clayton Dubilier & Rice are closing in on a deal to buy the largest independent provider of medical infusion services in the US, valuing the business at more than $5bn including debt.
Regulated by Hellenic Capital Market Commission
with Registration Number 5/700/10.12.2014

Copyright 2023©. All Rights Reserved